Inspiremd Inc stock is traded at $0.54, with a volume of 590,798. It is down -12.97% in the last 24 hours and up +23.15% over the past month. InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Previous Close:
$0.6205
Open:
$0.595
24h Volume:
590,798
Relative Volume:
1.06
Market Cap:
$29.23M
Revenue:
$10.85M
Net Income/Loss:
-$51.31M
P/E Ratio:
-
EPS:
-$0.737
Net Cash Flow:
-$36.77M
1W Performance:
-16.16%
1M Performance:
+23.15%
6M Performance:
-46.00%
1Y Performance:
-68.24%
1-Day Range:
$0.4999$0.632
1-Week Range:
$0.4999$0.69
52-Week Range:
$0.4254$2.17
Inspiremd Inc Stock (NSPR) Company Profile
Name
Inspiremd IncSector
HealthcareIndustry
Medical DevicesPhone
(888) 776-6804Address
6303 WATERFORD DISTRICT DRIVE, MIAMI, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS